Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Biofabrication ; 15(2)2023 02 03.
Artículo en Inglés | MEDLINE | ID: mdl-36689776

RESUMEN

Three-dimensional (3D) bioprinting is an emerging technology, which turned out to be an optimal tool for tissue engineering approaches. To date, different printing systems have been developed. Among them, the extrusion-based approach demonstrated to be the most suitable for skeletal muscle tissue engineering, due to its ability to produce and deposit printing fibers in a parallel pattern that well mimic the native skeletal muscle tissue architecture. In tissue bioengineering, a key role is played by biomaterials, which must possess the key requisite of 'printability'. Nevertheless, this feature is not often well correlated with cell requirements, such as motives for cellular adhesion and/or absorbability. To overcome this hurdle, several efforts have been made to obtain an effective bioink by combining two different biomaterials in order to reach a good printability besides a suitable biological activity. However, despite being efficient, this strategy reveals several outcomes limitations. We report here the development and characterization of a novel extrusion-based 3D bioprinting system, and its application for correction of volumetric muscle loss (VML) injury in a mouse model. The developed bioprinting system is based on the use of PEG-Fibrinogen, a unique biomaterial with excellent biocompatibility, well-suited for skeletal muscle tissue engineering. With this approach, we obtained highly organized 3D constructs, in which murine muscle progenitors were able to differentiate into muscle fibers arranged in aligned bundles and capable of spontaneously contracting when culturedin vitro. Furthermore, to evaluate the potential of the developed system in future regenerative medicine applications, bioprinted constructs laden with either murine or human muscle progenitors were transplanted to regenerate theTibialis Anteriormuscle of a VML murine model, one month after grafting.


Asunto(s)
Bioimpresión , Ingeniería de Tejidos , Ratones , Humanos , Animales , Ingeniería de Tejidos/métodos , Andamios del Tejido , Bioimpresión/métodos , Impresión Tridimensional , Músculo Esquelético , Materiales Biocompatibles
2.
Sci Rep ; 9(1): 5447, 2019 04 01.
Artículo en Inglés | MEDLINE | ID: mdl-30931986

RESUMEN

Heterotopic ossification (HO) is a pathological condition characterized by the deposition of mineralized tissue in ectopic locations such as the skeletal muscle. The precise cellular origin and molecular mechanisms underlying HO are still debated. In our study we focus on the differentiation of mesoangioblasts (MABs), a population of multipotent skeletal muscle precursors. High-content screening for small molecules that perturb MAB differentiation decisions identified Idoxuridine (IdU), an antiviral and radiotherapy adjuvant, as a molecule that promotes MAB osteogenic differentiation while inhibiting myogenesis. IdU-dependent osteogenesis does not rely on the canonical BMP-2/SMADs osteogenic pathway. At pro-osteogenic conditions IdU induces a mild DNA Damage Response (DDR) that activates ATM and p38 eventually promoting the phosphorylation of the osteogenesis master regulator RUNX2. By interfering with this pathway IdU-induced osteogenesis is severely impaired. Overall, our study suggests that induction of the DDR promotes osteogenesis in muscle resident MABs thereby offering a new mechanism that may be involved in the ectopic deposition of mineralized tissue in the muscle.


Asunto(s)
Diferenciación Celular , Daño del ADN , Células Madre Multipotentes/patología , Músculo Esquelético/patología , Osteogénesis , Animales , Proteína Morfogenética Ósea 2/metabolismo , Diferenciación Celular/efectos de los fármacos , Subunidad alfa 1 del Factor de Unión al Sitio Principal/metabolismo , Idoxuridina/farmacología , Células Madre Multipotentes/efectos de los fármacos , Músculo Esquelético/efectos de los fármacos , Osificación Heterotópica , Proteínas Smad/metabolismo
3.
Bioinspir Biomim ; 10(5): 056001, 2015 Aug 20.
Artículo en Inglés | MEDLINE | ID: mdl-26292037

RESUMEN

This work aims to demonstrate the feasibility of a novel approach for the development of 3D self-assembled polydimethylsiloxane structures, to be used as engineered flexible matrices for bio-hybrid actuation. We described the fabrication of engineered bilayers, organized in a 3D architecture by means of a stress-induced rolling membrane technique. Such structures were provided with ad hoc surface topographies, for both cell alignment and cell survival after membrane rolling. We reported the results of advanced finite element model simulations, predicting the system behavior in terms of overall contraction, induced by the contractile activity of muscle cells seeded on the membrane. Then, we tested in vitro the structure with primary cardiomyocytes to evaluate the real bio-actuator contraction, thus validating the simulation results. At a later stage, we provided the samples with a stable fibronectin coating, by covalently binding the protein on the polymer surface, thus enabling long-term cultures with C2C12 skeletal muscle cells, a more controllable cell type. These tests revealed cell viability and alignment on the rolled structures, but also the ability of cells to differentiate and to form multinucleated and oriented myotubes on the polymer surface, also supported by a fibroblast feeder layer. Our results highlighted the possibility of developing 3D rolled PDMS structures, characterized by different mechanical properties, as novel bio-hybrid actuators.


Asunto(s)
Órganos Bioartificiales , Dimetilpolisiloxanos/síntesis química , Contracción Miocárdica/fisiología , Miocitos Cardíacos/fisiología , Impresión Tridimensional , Andamios del Tejido , Animales , Biomimética/instrumentación , Células Cultivadas , Módulo de Elasticidad , Diseño de Equipo , Análisis de Falla de Equipo , Ratones , Miocitos Cardíacos/citología , Transductores
4.
Cell Death Dis ; 5: e1053, 2014 Feb 13.
Artículo en Inglés | MEDLINE | ID: mdl-24525729

RESUMEN

Cell-based regenerative therapies are significantly improved by engineering allografts to express factors that increase vascularization and engraftment, such as placental growth factor (PlGF) and matrix metalloproteinase 9 (MMP9). Moreover, the seeding of therapeutic cells onto a suitable scaffold is of utmost importance for tissue regeneration. On these premises, we sought to assess the reparative potential of induced pluripotent stem (iPS) cells bioengineered to secrete PlGF or MMP9 and delivered to infarcted myocardium upon a poly(ethylene glycol)-fibrinogen scaffold. When assessing optimal stiffness of the PEG-fibrinogen (PF) scaffold, we found that the appearance of contracting cells after cardiogenic induction was accelerated on the support designed with an intermediate stiffness. Revascularization and hemodynamic parameters of infarcted mouse heart were significantly improved by injection into the infarct of this optimized PF scaffold seeded with both MiPS (iPS cells engineered to secrete MMP9) and PiPS (iPS cells engineered to secrete PlGF) cells as compared with nonengineered cells or PF alone. Importantly, allograft-derived cells and host myocardium were functionally integrated. Therefore, survival and integration of allografts in the ischemic heart can be significantly improved with the use of therapeutic cells bioengineered to secrete MMP9 and PlGF and encapsulated within an injectable PF hydrogel having an optimized stiffness.


Asunto(s)
Fibrinógeno/química , Ingeniería Genética , Células Madre Pluripotentes Inducidas/trasplante , Metaloproteinasa 9 de la Matriz/metabolismo , Infarto del Miocardio/prevención & control , Miocardio/enzimología , Miocitos Cardíacos/trasplante , Polietilenglicoles/química , Proteínas Gestacionales/metabolismo , Regeneración , Ingeniería de Tejidos/métodos , Andamios del Tejido , Animales , Supervivencia Celular , Células Cultivadas , Modelos Animales de Enfermedad , Femenino , Hemodinámica , Células Endoteliales de la Vena Umbilical Humana/metabolismo , Humanos , Células Madre Pluripotentes Inducidas/enzimología , Masculino , Metaloproteinasa 9 de la Matriz/genética , Ratones , Ratones Endogámicos NOD , Ratones SCID , Contracción Miocárdica , Infarto del Miocardio/enzimología , Infarto del Miocardio/genética , Infarto del Miocardio/patología , Infarto del Miocardio/fisiopatología , Miocardio/patología , Miocitos Cardíacos/enzimología , Neovascularización Fisiológica , Factor de Crecimiento Placentario , Proteínas Gestacionales/genética , Recuperación de la Función , Factores de Tiempo , Transducción Genética , Transfección
5.
Philos Trans R Soc Lond B Biol Sci ; 359(1445): 745-51, 2004 May 29.
Artículo en Inglés | MEDLINE | ID: mdl-15293801

RESUMEN

We have employed transgenic methods combined with embryonic grafting to analyse the mechanisms of regeneration in Xenopus tadpoles. The Xenopus tadpole tail contains a spinal cord, notochord and segmented muscles, and all tissues are replaced when the tail regenerates after amputation. We show that there is a refractory period of very low regenerative ability in the early tadpole stage. Tracing of cell lineage with the use of single tissue transgenic grafts labelled with green fluorescent protein (GFP) shows that there is no de-differentiation and no metaplasia during regeneration. The spinal cord, notochord and muscle all regenerate from the corresponding tissue in the stump; in the case of the muscle the satellite cells provide the material for regeneration. By using constitutive or dominant negative gene products, induced under the control of a heat shock promoter, we show that the bone morphogenetic protein (BMP) and Notch signalling pathways are both essential for regeneration. BMP is upstream of Notch and has an independent effect on regeneration of muscle. The Xenopus limb bud will regenerate completely at the early stages but regenerative ability falls during digit differentiation. We have developed a procedure for making tadpoles in which one hindlimb is transgenic and the remainder wild-type. This has been used to introduce various gene products expected to prolong the period of regenerative capacity, but none has so far been successful.


Asunto(s)
Extremidades/fisiología , Regeneración/fisiología , Transducción de Señal/fisiología , Cola (estructura animal)/fisiología , Trasplantes , Xenopus/fisiología , Animales , Proteínas Morfogenéticas Óseas/fisiología , Diferenciación Celular/fisiología , Linaje de la Célula/fisiología , Extremidades/trasplante , Proteínas Fluorescentes Verdes , Proteínas Luminiscentes , Proteínas de la Membrana/fisiología , Receptores Notch
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA